Learn more

REDX PHARMA PLC

Overview
  • Total Patents
    160
  • GoodIP Patent Rank
    9,543
  • Filing trend
    ⇩ 90.0%
About

REDX PHARMA PLC has a total of 160 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2004. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are FOURNIER LAB SA, HEPAREGENIX GMBH and TAKEDA PHARMACEUTICALS CO.

Patent filings per year

Chart showing REDX PHARMA PLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bhamra Inder 37
#2 Bingham Matilda 31
#3 Testar Richard 29
#4 Donoghue Craig 23
#5 Cooper Ian 19
#6 Lyons Amanda 15
#7 Stokes Neil 15
#8 Armer Richard 13
#9 Sargent Louise 13
#10 Guisot Nicolas E S 12

Latest patents

Publication Filing date Title
GB202100526D0 Pharmaceutical formulation
GB202001344D0 Ras Inhibitors
GB201801226D0 Modulators of Rho-associated protein kinase
GB201704313D0 Antibacterial compounds
WO2017137743A1 Antibacterial compounds
AU2017218556A1 Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
GB201700484D0 Modulators of Rho-associated protein kinase
GB201700490D0 Modulators of rho-associated protein kinase
GB201616456D0 Antibacterial compounds
GB201616460D0 Antibacterial compounds
WO2017046603A1 Antibacterial compounds and new uses thereof
WO2017046606A1 Antibacterial compounds
GB201613947D0 Compounds
GB201613866D0 Antibacterial compounds
GB201612389D0 Modulators of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TD02)
GB201610412D0 Antibacterial compounds and a new uses thereof
GB201604258D0 Modulators of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO2)
GB201602234D0 Antibacterial compounds
GB201602235D0 Antibacterial compounds
GB201602241D0 Antibacterial compounds